2018 AANS Annual Scientific Meeting-586. Topical vancomycin reduces hospital costs associated with surgical-site infections in craniotomy

586. Topical vancomycin reduces hospital costs associated with surgical-site infections in craniotomy

Video Transcription

Video Summary

Dr. Arka Malala presented a talk on the use of topical vancomycin to reduce hospital costs associated with surgical site infections (SSIs) after craniotomy. It was mentioned that hospital-acquired infections account for about 1.7 million cases and 99,000 deaths per year, resulting in significant costs. The study showed an 81% reduction in the risk of SSIs with topical vancomycin, lowering the infection rate from 6% to 0.49%. Financially, the direct infection costs per patient were significantly lower in the vancomycin-treated group, totaling $13,000 compared to $206,000 in the control group. The estimated cost savings for 1,000 patients could exceed $1.3 million. The use of topical vancomycin was recommended for routine practice.

Asset Caption

Arka N Mallela, MS

Keywords

Dr. Arka Malala

topical vancomycin

surgical site infections

hospital costs

craniotomy